SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Cardiff Oncology Q3 net loss narrows 21% to $8.86 million

Cardiff Oncology Q3 net loss narrows 21% to $8.86 million Cardiff Oncology’s third-quarter 2026

CRDF

Related stories